LENZ OLIVER,LIN TSE-I,RABOISSON PIERRE JEAN-MARIE BERNARD
申请号:
NZ60255211
公开号:
NZ602552A
申请日:
2011.04.13
申请国别(地区):
NZ
年份:
2014
代理人:
摘要:
Provided is a combination comprising the macrocyclic inhibitor compound of formula I and the non-nucleoside inhibitor compound of formula III and its use in the treatment of hepatitis C virus (HCV) infections or diseases associated therewith. Additionally provided is the combination further comprising a nucleoside inhibitor, ribavirin or interferon.